Ā | No complications NĀ =ā405 | Minor only NĀ =ā73 | Major, at least one NĀ =ā22 | p-value |
---|---|---|---|---|
Demographic characteristics | ||||
āFemale | 271 (66.9%) | 46 (63.0%) | 12 (54.5%) | 0.425 |
āMean age, years (SD) | 67.8 (9.4) | 69.2 (9.7) | 65.5 (11.9) | 0.258 |
Primary Diagnosis: | Ā | Ā | Ā | 0.289 |
āOsteoarthritis | 390 (96.3%) | 70 (95.9%) | 20 (90.9%) | Ā |
āOther | 15 (3.7%) | 3 (4.1%) | 2 (9.1%) | Ā |
BMI (kg/m2): | Ā | Ā | Ā | . |
āā<ā18 | 0 (0.0%) | 1 (1.4%) | 0 (0.0%) | Ā |
āāā„ā18ā<ā25 | 42 (10.4%) | 9 (12.3%) | 2 (9.1%) | Ā |
āāā„ā25ā<ā30 | 97 (24.0%) | 17 (23.3%) | 4 (18.2%) | Ā |
āāā„ā30ā<ā35 | 134 (33.1%) | 19 (26.0%) | 8 (36.4%) | Ā |
āāā„ā35 | 132 (32.6%) | 27 (37.0%) | 8 (36.4%) | Ā |
Smoking: | Ā | Ā | Ā | 0.725 |
āNever smoked | 305 (75.3%) | 55 (75.3%) | 14 (63.6%) | Ā |
āPast smoker | 63 (15.6%) | 11 (15.1%) | 5 (22.7%) | Ā |
āCurrent smoker | 37 (9.1%) | 7 (9.6%) | 3 (13.6%) | Ā |
Co-morbidities | Ā | Ā | Ā | Ā |
āAnxiety or depression | 66 (16.3%) | 11 (15.1%) | 3 (13.6%) | 0.968 |
āAutoimmune disease | 11 (2.7%) | 0 (0.0%) | 2 (9.1%) | 0.064 |
āCardiovascular | 93 (23.0%) | 27 (37.0%) | 6 (27.3%) | 0.039 |
āChronic respiratory | 78 (19.3%) | 13 (17.8%) | 3 (13.6%) | 0.868 |
āCancer (current or past) | 52 (12.8%) | 8 (11.0%) | 2 (9.1%) | 0.924 |
āCerebrovascular | 26 (6.4%) | 7 (9.6%) | 4 (18.2%) | 0.078 |
āCentral nervous system (other) | 10 (2.5%) | 2 (2.7%) | 1 (4.5%) | 0.576 |
āDiabetes mellitus | 86 (21.2%) | 22 (30.1%) | 7 (31.8%) | 0.151 |
āDementia | 2 (0.5%) | 2 (2.7%) | 0 (0.0%) | 0.165 |
āGastro-intestinal or liver disease | 142 (35.1%) | 29 (39.7%) | 6 (27.3%) | 0.534 |
āHypertension | 271 (66.9%) | 59 (80.8%) | 13 (59.1%) | 0.038 |
āHyperlipidaemia | 165 (40.7%) | 30 (41.1%) | 7 (31.8%) | 0.702 |
āRenal impairment | 21 (5.2%) | 8 (11.0%) | 3 (13.6%) | 0.041 |
āHypothyroidism | 29 (7.2%) | 5 (6.8%) | 2 (9.1%) | 0.821 |
āVenous thromboembolism (past) | 19 (4.7%) | 0 (0.0%) | 0 (0.0%) | 0.125 |
āOsteoporosis | 17 (4.2%) | 5 (6.8%) | 0 (0.0%) | 0.514 |
āUrinary incontinence | 21 (5.2%) | 4 (5.5%) | 2 (9.1%) | 0.551 |
āUrinary tract infection (chronic) | 6 (1.5%) | 1 (1.4%) | 0 (0.0%) | 1.000 |
ASA Classification: | Ā | Ā | Ā | 0.370 |
ā1 | 21 (5.2%) | 2 (2.8%) | 1 (4.5%) | Ā |
ā2 | 201 (49.9%) | 28 (38.9%) | 9 (40.9%) | Ā |
ā3 | 180 (44.7%) | 42 (58.3%) | 12 (54.5%) | Ā |
ā4 | 1 (0.2%) | 0 (0.0%) | 0 (0.0%) | Ā |
āMissing | 2 (0.5%) | 1 (1.4%) | 0 (0.0%) | Ā |
Procedure: | Ā | Ā | Ā | 0.025 |
āTotal hip | 99 (24.4%) | 21 (28.8%) | 11 (50.0%) | Ā |
āTotal knee | 306 (75.6%) | 52 (71.2%) | 11 (50.0%) | Ā |
Number of joints: | Ā | Ā | Ā | 0.049 |
āUnilateral | 11 (2.7%) | 5 (6.8%) | 2 (9.1%) | Ā |
āBilateral | 394 (97.3%) | 68 (93.2%) | 20 (90.9%) | Ā |
āOperation time, minutes (SD) | 102.0 (24.7) | 110.7 (32.5) | 108.0 (30.1) | 0.026 |
āMedian length of Stay, days [range] | 4.0 [1.0;13.0] | 6.0 [2.0;21.0] | 5.0 [2.0;14.0] | <ā0.001 |
Length of Stay: | Ā | Ā | Ā | <ā0.001 |
āāā¤ā3ādays | 142 (35.1%) | 10 (13.7%) | 4 (18.2%) | Ā |
ā4 to 6 | 219 (54.1%) | 37 (50.7%) | 11 (50.0%) | Ā |
ā7 or more | 44 (10.9%) | 26 (35.6%) | 7 (31.8%) | Ā |
āHDU/ICU Admission | 13 (3.2%) | 7 (9.6%) | 4 (18.2%) | 0.001 |